Pyxis Oncology, Inc.
PYXS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782223
In the last 90 days, Pyxis Oncology, Inc. insiders filed 0 open-market purchases and 1 sale; 76 institutions reported holding it in 13F filings for Q2 2026, worth $101.1M in total; no superinvestor holds it.
Superinvestors holding PYXS, Q2 2026
No superinvestor reported holding PYXS in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of PYXS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2025
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−27.9%)
Q1 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−30.6%)
Q4 2021
1 superinvestor holding at quarter end